In order to provide a safe and effective vaccine for the Covid-19, the countries in the MENA region over the past few months have signed various collaborations with international pharma giants to conduct the Phase III clinical trials of COVID-19 vaccine candidates. Similarly, some of the regional pharma and biotech companies including Institute for Biological Research (IIBR), Migal Gaililee Research Institute, National Research Centre (NRC- Egypt) and others have shown potential and are working on homegrown vaccines.
Overall, the MENA region appears appealing for conducting research, establishing manufacturing units, and making tie-ups with pharma companies based there to advance in the pharmaceutical market and develop a safe and effective vaccine.
Source: Coronavirus Vaccines Trials In The MENA Region